Carl Kilander

Carl Kilander is a seasoned professional in the medical and biopharmaceutical fields, currently serving as a Partner and Medical Associate at HealthCap since August 2019. Kilander holds multiple directorial positions on various boards, including Rampart Bioscience, SwedenBIO, Adcendo, SynOx Therapeutics, and Aro Biotherapeutics. Prior experience includes research at Karolinska Institutet, focusing on biliary tract cancer and disease epidemiology, along with co-founding and leading Medify AB. Kilander's medical background encompasses residency at Capio Sverige and work as a medical doctor in emergency surgery and trauma at Karolinska University Hospital. Academic credentials include a Ph.D. in Medicine from Karolinska Institutet and studies at Harvard Medical School.